Skip to main navigation Skip to search Skip to main content

Primary peg-filgrastim prophylaxis versus filgrastim given “on demand” for neutropenia during therapy with cladribine for hairy cell leukemia

  • Tamar Tadmor
  • , Ilana Levy
  • , Yair Herishanu
  • , Neta Goldschmidt
  • , Osnat Bairey
  • , Mona Yuklea
  • , Lev Shvidel
  • , Riva Fineman
  • , Ariel Aviv
  • , Rosa Ruchlemer
  • , Andrei Braester
  • , Najib Dally
  • , Ory Rouvio
  • , Adir Shaulov
  • , Uri Greenbaum
  • , Michal Inbar
  • , Aaron Polliack
  • Bnai-Zion Medical Center
  • Technion-Israel Institute of Technology
  • Tel Aviv University
  • Hadassah University Medical Centre
  • Meir Hospital Sapir Medical Center
  • Kaplan Medical Center Israel
  • Rambam Health Care Campus
  • Emek Medical Center
  • Shaare Zedek Medical Center
  • Western Galilee Medical Center of Nahariya
  • Rebecca Sieff Government Hospital
  • Soroka Medical Center

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Primary peg-filgrastim prophylaxis versus filgrastim given “on demand” for neutropenia during therapy with cladribine for hairy cell leukemia'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science